UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Congenital Haemostasis Disorders and Urology Surgery: Is It Safe?

Journal of clinical medicine, 2024-04, Vol.13 (8), p.2357

2024

Link zum Volltext

Verfügbarkeit prüfen

Postoperative outcomes of elderly patients undergoing partial nephrectomy

Scientific reports, 2021-08, Vol.11 (1), p.17201-17201, Article 17201

2021

Link zum Volltext

Verfügbarkeit prüfen

Over-diagnosed prostate cancer in solid organ recipients: lessons from the last 3 decades

International urology and nephrology, 2021-02, Vol.53 (2), p.241-248

2021

Link zum Volltext

Verfügbarkeit prüfen

Positive surgical margin's impact on short-term oncological prognosis after robot-assisted partial nephrectomy (MARGINS study: UroCCR no 96)

Scientific reports, 2022-10, Vol.12 (1), p.18342-18342, Article 18342

2022

Link zum Volltext

Verfügbarkeit prüfen

Is CIS a Contraindication to Hyperthermic Intravesical Chemotherapy (HIVEC) after BCG-Failure?

Cancers, 2023-02, Vol.15 (5), p.1455

2023

Link zum Volltext

Verfügbarkeit prüfen

Urinary Continence Resolution after Bariatric Surgery: Long-Term Results after Six-Year Follow-Up

Journal of clinical medicine, 2023-03, Vol.12 (6), p.2109

2023

Link zum Volltext

Verfügbarkeit prüfen

UroPredict: Machine learning model on real-world data for prediction of kidney cancer recurrence (UroCCR-120)

NPJ precision oncology, 2024-02, Vol.8 (1), p.45-45, Article 45

2024

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial

The lancet oncology, 2022-05, Vol.23 (5), p.612-624

2022

Link zum Volltext

Verfügbarkeit prüfen

PD18-11 DELAYED PARTIAL NEPHRECTOMY FOLLOWING COMPLETE RESPONSE TO IMMUNOTHERAPY: FEASIBILITY AND RESULTS (UROCCR N°157)

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Link zum Volltext

Verfügbarkeit prüfen

Disease-free survival in operated patients with nmRCC using machine learning

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4539-4539

2023

Link zum Volltext

Verfügbarkeit prüfen

MP64-07 DEVELOPMENT OF AN INDIVIDUAL POSTOPERATIVE PREDICTION MODEL FOR KIDNEY CANCER RECURRENCE USING MACHINE LEARNING (UroCCR STUDY 120)

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure

World journal of urology, 2023-11, Vol.41 (11), p.3195-3203

2023

Link zum Volltext

Verfügbarkeit prüfen

Updated National Study of Functional Graft Renal Cell Carcinomas: Are They a Different Entity?

Urology (Ridgewood, N.J.), 2023-01, Vol.171, p.152-157

2023

Link zum Volltext

Verfügbarkeit prüfen

Individualized prediction of post-surgical pathologic T3a (pT3a) upstaging risk in localized renal tumors undergoing nephrectomy (UroCCR 15 study)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4547-4547

2022

Link zum Volltext

Verfügbarkeit prüfen

MP24-15 POSITIVE SURGICAL MARGINS AFTER ROBOT-ASSISTED PARTIAL NEPHRECTOMY (RAPN): DOES IT REALLY MATTER? (MARGINS STUDY – UroCCR 96)

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Link zum Volltext

Verfügbarkeit prüfen

Nephrometry scores to predict oncological outcomes following partial nephrectomy (UroCCR Study 70)

World journal of urology, 2023-12, Vol.41 (12), p.3559-3566

2023

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial

The lancet oncology, 2022-05, Vol.23 (5), p.612-624

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(30)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Congenital Haemostasis Disorders and Urology Surgery: Is It Safe?

Postoperative outcomes of elderly patients undergoing partial nephrectomy

Over-diagnosed prostate cancer in solid organ recipients: lessons from the last 3 decades

Positive surgical margin's impact on short-term oncological prognosis after robot-assisted partial nephrectomy (MARGINS study: UroCCR no 96)

Is CIS a Contraindication to Hyperthermic Intravesical Chemotherapy (HIVEC) after BCG-Failure?

Clinical trial protocol for P-NeLoP: a randomized controlled trial comparing the feasibility and outcomes of robot-assisted partial nephrectomy with low insufflation pressure using AirSeal versus standard insufflation pressure (UroCCR no. 85 study)

Urinary Continence Resolution after Bariatric Surgery: Long-Term Results after Six-Year Follow-Up

UroPredict: Machine learning model on real-world data for prediction of kidney cancer recurrence (UroCCR-120)

Preparing for the Worst: Management and Predictive Factors of Open Conversion During Minimally Invasive Renal Tumor Surgery (UroCCR-135 Study)

The Impact of Histological Variants on Oncological Outcomes After Surgical Resection of a Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus: A Multi-institutional Study

Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial

PD18-11 DELAYED PARTIAL NEPHRECTOMY FOLLOWING COMPLETE RESPONSE TO IMMUNOTHERAPY: FEASIBILITY AND RESULTS (UROCCR N°157)

MP56-14 THE IMPACT OF HISTOLOGICAL VARIANTS ON ONCOLOGICAL OUTCOMES AFTER SURGICAL RESECTION OF A NONMETASTATIC RENAL CELL CARCINOMA WITH TUMOR THROMBUS: A MULTI-INSTITUTIONAL STUDY

Disease-free survival in operated patients with nmRCC using machine learning

MP64-07 DEVELOPMENT OF AN INDIVIDUAL POSTOPERATIVE PREDICTION MODEL FOR KIDNEY CANCER RECURRENCE USING MACHINE LEARNING (UroCCR STUDY 120)

Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure

Updated National Study of Functional Graft Renal Cell Carcinomas: Are They a Different Entity?

Individualized prediction of post-surgical pathologic T3a (pT3a) upstaging risk in localized renal tumors undergoing nephrectomy (UroCCR 15 study)

MP24-15 POSITIVE SURGICAL MARGINS AFTER ROBOT-ASSISTED PARTIAL NEPHRECTOMY (RAPN): DOES IT REALLY MATTER? (MARGINS STUDY – UroCCR 96)

Machine‐learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma ( UroCCR ‐15)

Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-Institutional, Prospective Study (UROCCR Study 82)

Machine‐learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR‐15)

ASO Visual Abstract: Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-institutional, Prospective Study (UROCCR Study 82)

Nephrometry scores to predict oncological outcomes following partial nephrectomy (UroCCR Study 70)

Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial

Suchergebnisse filtern